Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's Disease

Recent news which mentions Alzheimer's Disease

< Previous 1 2 3 Next >
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Politics Breaking News: Business Business News
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags U/S/ Economy Coronavirus Politics
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags Science Politics Breaking News: Business
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Companies Science Biogen Inc
From CNBC.com News
March 2023 Miscellany
Tags Eisai (ESALY) Merck (MRK) Prostate Cancer
From Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
Tags Doc Gumshoe Anavex Life Sciences (AVXL) Parkinson's Disease
From Stock Gumshoe
Relevant Updates – December 2022
Tags Bavarian Nordic (BAVA/CO BVNRY BVNKF) Lexeo Therapeutics influenza
From Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Tickers MOR RHHBF RHHBY RHHVF
Tags Biotech RHHBF Briefs
From Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
Tags Health Longevity rates Self/improvement
From CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
Tickers SPRC
Tags Cannabis medical cannabis General
From Benzinga
Odd & Ends – October 2022
Tags Eisai (ESALY) Alzheimer's Disease Eli Lilly (LLY)
From Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Tickers ABOS ACIU ALZN ANVS
Tags Biotech SAVA Market News
From Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags Analyst Color Marc Goodman lecanemab
From Benzinga
Following Up on Your Suggestions – September 2022
Tickers DIET
Tags Johnson and Johnson (JNJ) inflammation Rheumatoid Arthritis
From Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
Tickers DGX
Tags Research, Reports & Publications Health & Healthcare Dr Pat Alagia
From 3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
Tickers CGTX
Tags News Health Care Benzinga
From Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
Tags TauRX Pharmaceuticals Alzheimer's Disease INmune Bio (INMB)
From Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
Tickers ABBV ALEC
Tags General ALEC Alzheimer's disease
From Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
Tags Alzheimer's Disease TauRX Pharmaceuticals Cassava Sciences (SAVA)
From Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
Tickers BIIB
Tags News Health Care Benzinga
From Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
Tags Doc Gumshoe Biogen Idec (BIIB) Alzheimer's Disease
From Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Briefs BIIB ESALF
From Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
Tickers SAVA
Tags SAVA Biotech Small Cap
From Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
Tickers LGVN
Tags Alzheimer's disease Market News General
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags Market News BIIB Biotech
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Tickers LGVN
Tags Biotech Exclusives Market News
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags ESALY Alzheimer's disease Market News
From Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Tickers BIIB
Tags Benzinga Health Care Phase 3 Trial
From Benzinga
Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs
Tickers PRTA
Tags Preclinical Phase Benzinga Health Care
From Benzinga
Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs
Tickers GANX
Tags Briefs Biotech Market News
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.